Information center / Breast cancer / Cancer / Prevention / Science / Women's health
Why racial diversity matters in breast cancer clinical trials
![](https://b829170.smushcdn.com/829170/wp-content/uploads/2022/10/pexels-photo-1181724-1024x683.jpeg?lossy=1&strip=1&webp=1)
(Carly Werner/ Healthline) — Clinical trials are key to learning about conditions like cancer and finding new treatments. These trials, which happen after years of research, are a chance to try out promising new therapies in people.
Current treatments for breast cancer were once tested in clinical trials.
Many women have benefited from being a part of a clinical trial. Lives have been improved, prolonged, and saved as a result of clinical trials.
But People of Color often face barriers in accessing healthcare. They also have lower rates of participation in clinical trials. (…)
Categories